En anglais seulement.
Définitions : le sexe et le genre
Définitions : « les femmes »
- THEME 1 | Opportunities to Act: Practicing Cultural Humility and Embedding Cultural Safety into Practice
- THEME 2 | New Evidence / Emerging Risk Factors and Opportunities to Act
- THEME 3 | Opportunities to Act: Screening and Diagnosis
- THEME 4 | Opportunities to Act: Acute Care
- THEME 5 | Opportunities to Act: Health Systems
- THEME 6 | Opportunities to Act: Mental Health and Cognitive Impairment
- THEME 7 | Opportunities to Act: Review of Menopause and Pregnancy Guidelines
- THEME 8 | Opportunities to Act: Rehabilitation, Recovery and Support
Friday, April 28, 2023
7:00 - 8:00 am
Continental Breakfast and Registration
8:00 - 8:30 am
Welcome Remarks
Elder Syex̱wáliya Ann Whonnock Knowledge Carrier & Elder Squamish Nation |
|
|
Tara Sedlak, MD, FRCPC, MBA |
|
Allen and Karen Wong |
|
Thierry Mesana, MD |
|
Doug Roth |
|
Thais de A. Coutinho, MD |
8:30 - 9:30 am
Theme 1: Opportunities to Act: Practicing Cultural Humility and Embedding Cultural Safety into Practice
Changing Our Practice to be Inclusive & Doing the Work of Reconciliation
By the end of the session, participants will be able to describe the structures, processes, relationships, roles & responsibilities of providing culturally safe health care.
Evan Adams, MD, MPH |
Black Women and Heart Disease: Time to Start Seeing Colour
By the end of the session, participants will be able to identify how to close research and clinical gaps cardiovascular risk and disease management for Black women.
Alexandra Bastiany, MD, FRCPC, DRCPSC |
Gestational Diabetes in South Asian Women: The Start of a Vicious Cycle
By the end of the session, participants will be able to identify how to close research and clinical gaps in cardiovascular risk and disease management for South Asian women.
|
Sonia Anand, MD, PhD, FRCPc |
Risk of Stroke in Immigrant Women: The Role of Intersecting Identities
By the end of the session, participants will be able to describe the gap in brain and/or vascular risk and disease management for immigrant women and how to close this gap.
|
Manav Vyas, MBBS, MSc, PhD, FRCPC, CSCN (EEG) |
9:30 - 9:50 am
Morning Break
9:50 - 10:30 am
Keynote Address: The Lancet Women and Cardiovascular Disease Commission: Reducing the Global Burden by 2030
By the end of the session, participants will be able to describe action-oriented initiatives to reduce cardiovascular disease morbidity and mortality rates for women in Canada.
|
Roxana Mehran, MD, FACC, FACP, FCCP, FESC, FAHA, MSCAI |
10:30 - 11:30 am
Theme 2: New Evidence / Emerging Risk Factors and Opportunities to Act
My Story of Familial Hypercholesterolemia
By the end of the session, participants will be able to describe a woman with lived experience’s heart journey through diagnosis, surgery and pregnancy.
Kelly Brady Woman with Lived Experience Squamish, BC |
Atrial Fibrillation and Stroke
By the end of the session, participants will have knowledge of sex differences in the risk, diagnosis, management and outcomes of atrial fibrillation and stroke.
|
Jodi Edwards, PhD |
Sex Differences in Familial Hypercholesterolemia and Atherosclerotic Cardiovascular Disease
By the end of the session, participants will be able to identify sex differences in familial hypercholesterolemia and cardiovascular disease.
|
Liam Brunham, MD, PhD, FRCPC, FACP, FNLA |
Optimizing Cardiac Outcomes in Breast Cancer Patients
By the end of the session, participants will be able to identify emerging evidence around cardiovascular disease and breast cancer therapies.
|
Margot Davis, MD, MSc, FRCPC |
11:40 - 12:15 pm
Concurrent Breakout Sessions
1. Special Considerations of Congenital Heart Disease in Pregnancy
By the end of the session, participants will be able to have a general approach to common congenital heart lesions in pregnancy.
|
Jasmine Grewal, MD |
2. Advances in Genetic Testing:
Insights into the Pathophysiology and Management of Cardiomyopathies in Women
By the end of the session, participants will be able to identify and explain cardiomyopathies in women and the impact of sex.
|
Gavin Y. Oudit, MD, PhD, FRCPC |
Genetic Testing in a Polygenic World: What is the Fuss About Polygenic Scores
By the end of the session, participants will be able to describe core principles of polygenic scores and their applications.
|
Guillaume Paré MD, MSc, FRCP(c) |
3. Underdiagnosis and Misdiagnosis of Coronary Microvascular Dysfunction in Women: How Can We Do Better?
By the end of the session, participants will be able to describe coronary microvascular dysfunction (CMD) with respect to epidemiology, diagnosis and therapy and ways to avoid underdiagnosis and misdiagnosis of CMD.
|
Denise L. Johnson |
|
Tara Sedlak, MD, FRCPC, MBA |
4. Younger Women: Stroke and Heart Disease Focus
By the end of the session, participants will be able to identify the incidence/prevalence of heart and stroke diagnoses among younger women and discuss recommendations for future research and practice.
|
Aleksandra Pikula, BSc. (Hon), MD, Dipl. ABPN (USA), Dipl. ABLM (USA), FAHA |
Louise Pilote MD, MPH, PhD, FRCPC |
12:15 - 1:15 pm
Oceanview Suites: Lunch
12:30 - 1:10 pm
Live Streamed Lunch & Learn: Meaningful Engagement in Research
Having a Voice – How WWLE Can Partner with the Healthcare Community on Conferences, Research, Advocacy, Health Education, Policy Work and Quality Improvement
By the end of the session, participants will be able to list tips on how patient advocates can navigate for meaningful engagement and avoid tokenism.
|
Jennifer Monaghan, BA, LLB |
Meaningful Patient Engagement in Research
Discuss the challenges and potential solutions for researchers to incorporate meaningful patient engagement strategies.
Jillianne Code, PhD |
Better Medicine Together: a New Platform for Medical Research Collaboration and Funding
By the end of the session, participants will be able to discuss ways in which patient advocates, researchers, and funders can work together for a more inclusive, democratized approach to medical research.
|
Rosalie (Rose) McDonough, MD |
12:25 - 1:10 pm
Pacific Room 1: Trainee Career Mentoring Session
|
Karin H. Humphries, MBA, DSc, FAHA |
|
Tara Sedlak, MD, FRCPC, MBA |
1:15 - 2:00 pm
THEME 3: Opportunities to Act: Screening and Diagnosis
Not Taking No for an Answer
By the end of the session, participants will be able to describe Michelle’s journey through the healthcare system from symptom recognition to disease diagnosis, treatment and outcomes.
|
Michelle Logeot |
Approach to the Diagnostics and Management of Ischemia with No Obstructive Coronary Artery Disease
By the end of the session, participants will be able to describe a diagnostic pathway and therapeutic approach to the management of patients presenting with signs and/or symptoms of suspected ischemia with no obstructive coronary artery disease.
|
Judy Luu, MD/PhD, FRCPC |
MINOCA: Contemporary Diagnosis and Management
By the end of the session, participants will be able to identify diagnostic modalities and describe appropriate management of patients presenting with myocardial infarction with no obstructive coronary artery disease (MINOCA).
|
Christine Pacheco, MD, MSc, FRCPC |
2:00 - 2:45 pm
THEME 4: Opportunities to Act: Acute Care
From Flu to Heart Transplant - Naomi's Story
By the end of the session, participants will be able to describe a woman’s journey through the healthcare system from symptom recognition to disease diagnosis, treatment and outcomes.
|
Naomi Lee |
The Impact of Sex and Gender on Acute Stroke Diagnosis and Care
By the end of the session, participants will be able to recognize the differences (and similarities!) of stroke symptoms in men and women.
|
Amy Yu, MDCM, MSc, FRCPC |
A Novel Chest Pain Algorithm for Earlier Recognition of Cardiac Ischemia in Women
By the end of this session, you will be equipped with a new algorithm on the timely recognition and differentiation of ischemic and non-ischemic chest pain presentations in women.
|
Anita Pozgay, MD, FRCPC, Dip Sport Med |
|
Meagan Noble, BA(Kin), BScN, MN-CSRS, NP-Adult |
2:45 - 3:05 pm
Afternoon Break
3:05 - 3:50 pm
THEME 5: Opportunities to Act: Health Systems
The Other Face of Heart Disease
By the end of the session, participants will be able to describe Barb’s journey through the healthcare system from symptom recognition to disease diagnosis, treatment and outcomes.
|
Barb Hess |
From Planning to Delivery – A Case Study in the Implementation of a Regional Women’s Cardiovascular Health Initiative
By the end of the session, participants will be able to describe key considerations related to implementing women-focused cardiovascular health programs.
|
Kerri-Anne Mullen, PhD |
Examining the Intersection Between Sex- and Gender-Based Considerations and Telerehabilitation in Individuals with Stroke
By the end of the session, participants will be able to identify how sex and gender considerations can be incorporated in healthcare for individuals with stroke.
|
Elise Wiley, MSc |
3:50 - 4:50 pm
Theme 6: Opportunities to Act: Mental Health and Cognitive Impairment
If You’re Going to Have a Stroke, Don’t be a Woman.
By the end of the session, participants will learn about a type of medical unthinking and unseeing through Rebecca’s reflections on the female care experience, the female body, and invisible disabilities in an intensive stroke rehabilitation unit.
|
Rebecca Henderson, MSc |
Cognitive Health Begins with the Aorta – Understanding the Role of Aortic Function on Cognition
By the end of this session, participants will be able to describe the pressure-buffering function of the aorta as a key function to protect the brain and cognition.
|
Thais de A. Coutinho, MD |
Cognitive Rehabilitation – Implications and Strategies for Women After Stroke
By the end of the session, participants will be able to identify some strategies on how to manage post stroke cognitive changes, and how these changes impact women with lived experience of stroke.
Jennifer K. Yao, MD, FRCPC |
Social Isolation, Loneliness, and Cardiovascular Disease Among Women
By the end of the session, participants will learn how social isolation and loneliness are connected to cardiovascular disease and how social connectedness can bolster cardiovascular health among women.
|
Karen Bouchard, PhD |
4:50 - 5:00 pm
Day 1 Closing Remarks
|
Tara Sedlak, MD, FRCPC, MBA |
5:00 - 6:00 pm
Wine and Cheese Poster Session
6:30 - 10:00 pm
Networking Dinner
Saturday, April 29, 2023
7:00 - 8:00 am
Continental Breakfast and Registration
8:00 - 8:45 am
Patient-Centered Care: Engaging Care Providers to be More Inclusive of Patient Perspectives and Circumstances When Developing a Treatment Plan
Kelly's Story
By the end of the session, participants will be able to describe Kelly’s journey through the healthcare system from symptom recognition to disease diagnosis, treatment and outcomes.
|
Kelly Saylor |
Why Your Patient is Not Following Your Advice
By the end of the session, participants will be able to describe a number of previously hidden obstacles to heart patient adherence to treatment goals.
|
Carolyn Thomas |
Closing the Gap Between Good Intentions and Improved Outcomes: Implementation of Shared Decision-Making
By the end of the session, participants will be able to discuss the value of shared decision-making in cardiac care, explore the opportunities and challenges of implementation and consider strategies to empower patients to achieve a good treatment decision.
|
Sandra Lauck PhD, RN FCAN FESC |
8:45 - 9:30 am
Pregnancy: The Impact on Heart, Brain and Vascular Health
Unlocking Lifetime Cardiovascular Risk with Placenta Pathology
By the end of the session, participants will be able to describe how clinical and automated placenta pathology can identify women at highest risk for poor cardiovascular health in the future.
Shannon Bainbridge, PhD |
Cardiovascular Disease in Pregnancy: Impact on Future Risk of CVD
By the end of the session, participants will be able to identify pregnant women at risk of cardiovascular risk factors and disease in the future.
|
Jasmine Grewal, MD |
Pregnancy and Stroke
By the end of the session, participants will be able to identify the impact of pregnancy on the risk of future stroke.
Noor Niyar N. Ladhani, MD, MPH, FRCSC |
9:30 - 10:30 am
THEME 7: Opportunities to Act: Review of Menopause and Pregnancy Guidelines
From Avoidance to Empowerment and Some Tools to Get There!
By the end of the session, participants will be able to describe a woman’s journey through the healthcare system from symptom recognition to disease diagnosis, treatment and outcomes.
|
Risa Mallory, MEd |
Guideline No. 422e: Menopause and Cardiovascular Disease
By the end of the session, participants will be able to describe the cardiovascular safety of menopausal hormone therapy and discuss the differences of cardiovascular safety profile among hormone therapy options and women at risk.
|
Beth Abramson, MD, MSC, FRCPC, FACC |
Presentation Title - Coming Soon!
By the end of the session, participants will be able to describe the current pregnancy and stroke guidelines.
|
Rick Swartz, MD, PhD |
Presentation Title - Coming Soon!
By the end of the session, participants will be able to describe the current Canadian screening and treatment guidelines for cardiovascular disease prevention after preeclampsia.
|
Kara Nerenberg, MD, MSc |
10:30 - 10:50 am
Morning Break
10:50 - 11:35 am
Concurrent Breakout Sessions
1. Pharmaceuticals 101:
Does an Aspirin a Day Keep the Doctor Away?
By the end of the session, participants will be able to identify commonly recommended medications for coronary artery disease and heart failure and describe how they improve outcomes as well as relevant sex-specific considerations.
|
Habibat A. Garuba, MD, FRCPC, BScPhm (Hons) |
The ABC’s of Pharmacy Post Stroke
By the end of the session, participants will be able to describe anticoagulation, blood pressure and cholesterol management post stroke as well as relevant sex-specific considerations.
|
Harjinder Parwana, BSc(Pharm.), ACPR, PharmD |
Thalia Field, MD, FRCPC, MHSc |
2. Focus on Education: The Need for Women’s Heart Health Content in Medical and Nursing Curricula and Sex and Gender-based Analysis Training for Research Trainees
By the end of this session, participants will be to identify gaps in women’s heart health content in current medical and nursing curricula and describe a possible strategy for incorporating a sex and gender based lens.
|
Najah Adreak, MD, MSc |
|
Cindy Kalenga, PhD |
3. Canadian Women's Heart Health Alliance: Making Change Happen
By the end of the session, participants will understand how the CWHHA is collaboratively driving healthcare equity in Canada and improving women's cardiovascular health across their life span.
|
Helen Robert |
|
Lisa Comber, KTPC, BA |
4. Relationship of Long-COVID and CVD
By the end of the session, participants will be able to explain the impact of long-COVID, and identify the relationship between long-COVID and cardiovascular disease, and the different presentations of Long-COVID based on sex.
|
Paula Henderson |
|
Satish R Raj, MD, MSCI, FRCPC |
11:45 - 12:15 pm
Heart Failure and Diabetes: The Impact of Diastolic Dysfunction in Women
|
Kim Connelly MBBS PhD FSCMR FCCS |
12:15 - 1:15 pm
Oceanview Suites: Lunch
1:15 - 2:15 pm
THEME 8: Opportunities to Act: Rehabilitation, Recovery and Support
Building Confidence after a Heart Health Shock
By the end of this session, participants will be able to describe the impact of rehabilitation and support in a woman’s confidence that translates to the success of her recovery after receiving a heart disease or heart failure diagnosis.
|
Jackie Ratz, BA Hons |
Cardiac Rehab: Evidence-Based Approaches to Tailor Programs to Best Meet Women’s Needs and Improve Outcomes
By the end of the session, participants will be able to identify implementable strategies to optimize cardiac rehabilitation delivery for women.
|
Sherry Grace, PhD, CRFC |
2:15 - 3:00 pm
Rapid Fire Oral Presentations
By the end of the session, participants will be able to interpret new experiences, insights, and latest research results in the field of women’s heart, brain and vascular health.
1. Influence of Neighbourhood-Level Proportion of Visible Minorities in Prevalence of Hypertensive Disorders of Pregnancy
A Johnston, W Petrcich, DB Fell, P Tanuseputro, GN Smith, T Coutinho, JD Edwards
Abstract Summary: From 2002-2020, Ontario neighborhoods with the highest proportion of visible minorities had the lowest proportion of residents with hypertensive disorders of pregnancy (HDP), suggesting neighborhood characteristics may play a role in HDP risk. Future work should examine whether other factors account for this association.
|
Amy Johnston, MSc, MBT, CPH |
2. Resiliency-Focused Approaches to Understanding & Mending ‘Broken’ Hearts: Reporting on Three Community-Based Storytelling Events with First Nations Community Partners
B Downey, A Lepine, H Healey
Abstract Summary: In line with the goals of the Mending Broken Hearts (MBH) community-based participatory research project; summary of preliminary findings from two community-based storytelling events facilitated with two First Nations are presented.
|
Bernice Downey, PhD, RN, BScN |
|
Alexandra Lepine |
|
Hannah Healey |
3. Testosterone Treatment Impairs Cardiac Function and Fatty Acid Metabolism in a Rodent Model of Polycystic Ovary Syndrome
M Horkey, X Wu, R Watts, R Lehner, M Ghosh, P Raggi, H Becher, S Proctor, D Vine
Abstract Summary: Polycystic Ovary Syndrome is associated with excess androgen levels and increased cardiovascular disease risk, however the mechanisms of androgen regulation of cardiac function and cardiometabolic risk factors remain unclear. In a PCOS-prone rodent model we demonstrate that androgens modulate cardiac structure and function, and this is associated with altered fatty acid metabolism. These effects may help to explain premature cardiovascular disease risk in the hyperandrogenemic conditions of PCOS.
|
Donna Vine, PhD |
4. Understanding the Intersectionality of Risk Factors of Hypertensive Disorders of Pregnancy in Women of African and Caribbean Descent in High Income Countries – A Scoping Review
D Baiden, M Parry, K Nerenberg, E M Hillan, M J Dogba, S Adombire
Abstract Summary: Using the concept of intersectionality, this scoping review reveals the multidimensional nature of risk factors of hypertensive disorders of pregnancy in women of African and Caribbean descent in high income countries.
Deborah Baiden, RN, MScN |
Exploring Abnormalities in Pulsatile Arterial Load as Distinct Features of the HFpEF Syndrome in Women
R Crosier, L Mielniczuk, P Liu, R Beanlands, T Coutinho
Abstract Summary: Women with heart failure and preserved ejection fraction display abnormal arterial hemodynamics. Targeting pulsatile arterial load may be a tool to detect and treat heart failure in women.
Rebecca Crosier, MD |
3:00 - 3:20 pm
Afternoon Break
3:20 - 3:50 pm
Presentations Attitutes and Beliefs: Recognition and Remediation of Unconscious Sex and Gender Bias by HealthCare Professional Regarding Diagnosis, Treatment and Rehabilitation
By the end of the session, participants will be able to identify strategies to overcome unconscious sex and gender bias in the healthcare setting.
|
Christina and Sven Stuwe |
|
Varinder Randhawa, MD, PhD |
3:50 - 4:30 pm
Closing Keynote Address: Reimagining Healthcare in Canada: Artificial Intelligence and Sex/Gender to Drive Change
By the end of the session, participants will be able to discuss issues involving sex/gender differences in access and delivery of cardiovascular care at a population level; international differences in cardiovascular practice patterns and outcomes; and health economics.
|
Padma Kaul, PhD |
4:30 - 5:00 pm
Awards Ceremony and Closing Remarks
|
Karin H. Humphries, MBA, DSc, FAHA |
|
|
Tara Sedlak, MD, FRCPC, MBA |
|
|
Allen and Karen Wong |
|
|
Thais de A. Coutinho, MD |
Quelle est la différence entre le sexe et le genre?
Les mots « sexe » et « genre » sont souvent utilisés de façon interchangeable même si chacun a une définition claire et distincte.
L’équipe du Sommet fera de son mieux pour respecter ces définitions dans ses documents et communications. Il est toutefois possible que ces termes soient parfois utilisés de manière incorrecte ou interchangeable dans le contenu présenté.
- Le sexe renvoie à des attributs biologiques principalement liés à des caractéristiques physiques et physiologiques (hormones, gènes, anatomie, physiologie, etc.), et est généralement associé aux catégories « hommes » et « femmes ».
- Le genre renvoie à des rôles, comportements, expressions et identités socialement construits et, par comparaison, est généralement associé aux catégories « femmes/filles » et « hommes/garçons ».
Pour obtenir des renseignements sur les sommets précédents :
- Sommet canadien sur la santé cardiaque des femmes de 2018 (en anglais seulement)
- Journal canadien de cardiologie, Juin 2017- Cap sur la santé cardiaque des femmes au Canada : recommandations du premier Sommet canadien sur la santé cardiaque des femmes (en anglais seulement)
- The Beat, Juin 2017 - Tracer la voie pour la santé cardiaque des femmes au Canada
- Sommet canadien sur la santé cardiaque des femmes de 2016 (en anglais seulement)